A Study Evaluating Safety and Tolerability of YM150 Compared to Warfarin in Subjects With Atrial Fibrillation
Clinical trial NCT00938730 · COMPLETED
Trial details
- NCT number
- NCT00938730
- Sponsor
- Astellas Pharma Inc
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-06-01
- Primary completion
- 2010-09-01
- Enrollment
- 1280
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.